TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2023-09-19
賴瓊慧Lai, Chyong-Huey
- 計畫主持人
- 執行臨床試驗年資 23 年 9 個月
-
laich46@cgmh.org.tw
發表文獻
25筆
11
Invited panelist “Cervical cancer control: cervical screening and HPV vaccination program and research in Chinese Taipei” in the 2020 APEC LSIF-HWG Policy Dialogue on Cervical Cancer. November 20-24, 2020, Malaysia.
12
Invited speaker “What’s next for PARP inhibitors? PARPi resistance and ways to overcome” in the 6th International Workshop of the Asian Society of Gynecologic Oncology. December 19-20, 2020, Taipei, Taiwan.
13
Invited speaker “Present Status and Future Perspectives of Clinical Trial from TGOG” in JGOG-KGOG-TGOG-CGCS Joint Session “Building a Clinical Trial Network in East Asia: Present Status and Future Perspectives” of the 63th Annual Meeting of Japan Society of Gynecologic Oncology Meeting (virtual), July 17-18, 2021, Japan.
14
Session Chair “The role of medical women in the future.” In the 2021 Western Pacific Medical Women’s International Association Regional Meeting (virtual), August 20-21, 2021, Korea.
15
Invited speaker “Elimination of cervical cancer by 2030-Situation analysis in Taiwan” in the 2021 Central Asia Regional Conference of Medical Women’s International Association (virtual), September 11-12, 2021, India.
16
Invited speaker “Elimination of cervical cancer by 2030-Situation analysis in Taiwan” in the 2021 Central Asia Regional Conference of Medical Women’s International Association (virtual), September 11-12, 2021, India.
17
Invited speaker “Elimination of cervical cancer by 2030-Situation analysis in Taiwan” in the 2021 Central Asia Regional Conference of Medical Women’s International Association (virtual), September 11-12, 2021, India.
18
Invited speaker “Elimination of cervical cancer by 2030-Situation analysis in Taiwan” in the 2021 Central Asia Regional Conference of Medical Women’s International Association (virtual), September 11-12, 2021, India.
19
Session Chair “Innovative Methods for Rare Disease Drug Development” in the 2021 Conference of Critical Clinical Initiatives in Drug Development-Adaptive Designs, Precision Medicine, and RWD/RWE, September 17, 2021, Taoyuan, Taiwan.
20
Invited speaker “Prevalence and genotype distribution of HPV in lower genital tract in Taiwanese women” in the 2021 Taiwan HPV Vaccination Policy Summit (hybrid), October 23, 2021, Taiwan.
